Enhanced antibacterial and anticancer activities of plant extract mediated green synthesized zinc oxide-silver nanoparticles
Frontiers in Microbiology · 24.07.2023 · 14
DOI: 10.3389/fmicb.2023.1194292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 24.07.2023. Verfasst von Siti Nur Amalina Mohamad Sukri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study presents a green synthesis approach for the fabrication of zinc oxide-silver nanoparticles (ZnO-Ag-NPs) using Punica granatum fruit peels extract as a natural reducing and stabilizing agent. This eco-friendly method offers a sustainable alternative to conventional methods that often employ toxic or hazardous chemicals. Antibacterial and anti-cancer activities of the green synthesized nanoparticles were then assessed in vitro . X-ray diffraction confirmed the production of ZnO-Ag-NPs with increasing crystallinity in higher pH values. The ZnO-Ag-NPs were found to be agglomerated with spherical Ag-NPs. Fourier Transform Infrared (FTIR) spectra revealed a broad band in ZnO-Ag-NPs ranging from 400 −1 to 530 cm −1 with reduced intensity as compared to ZnO-NPs, indicating the formation of Ag-NPs on the surface of ZnO-NPs. The synthesized ZnO-Ag-NPs exhibited potent antibacterial activity against a broad spectrum of bacterial strains, particularly Gram-positive bacteria, with superior inhibition activity compared to ZnO-NPs. Moreover, ZnO-Ag-NPs showed a dose-dependent anti-proliferative effect on colorectal-, lung-, and cervical cancer cells. ZnO-Ag-NPs showed significantly greater efficacy in inhibiting cancer cell growth at a lower concentration of 31.25 μg/mL, compared to ZnO-NPs which required over 500 μg/mL, possibly due to the presence of silver nanoparticles (Ag-NPs). The results obtained from this study demonstrate the potential of green synthesis approaches in the fabrication of therapeutic nanomaterials for cancer treatment, as well as other biomedical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia.
- School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
- Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, Zhejiang, China.
- Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
- School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia.
- Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
Zitieren
APA
Mohamad Sukri, S. N. A., Shameli, K., Teow, S. Y., Chew, J., Ooi, L. T., Lee-Kiun Soon, M., Ismail, N. A., & Moeini, H. (2023). Enhanced antibacterial and anticancer activities of plant extract mediated green synthesized zinc oxide-silver nanoparticles. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1194292
Vancouver
Mohamad Sukri SNA, Shameli K, Teow SY, Chew J, Ooi LT, Lee-Kiun Soon M, et al. Enhanced antibacterial and anticancer activities of plant extract mediated green synthesized zinc oxide-silver nanoparticles. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1194292
BibTeX
@article{MohamadSukri2023,
author = {Mohamad Sukri, Siti Nur Amalina and Shameli, Kamyar and Teow, Sin-Yeang and Chew, Jactty and Ooi, Li-Ting and Lee-Kiun Soon, Michiele and Ismail, Nur Afini and Moeini, Hassan},
title = {Enhanced antibacterial and anticancer activities of plant extract mediated green synthesized zinc oxide-silver nanoparticles},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1194292}
}
EUVIMED